Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn’s Disease

被引：0
|
作者：
Jonathan M. Rhodes
Sreedhar Subramanian
Paul K. Flanagan
Graham W. Horgan
Kate Martin
John Mansfield
Miles Parkes
Ailsa Hart
Helen Dallal
Tariq Iqbal
Jeffrey Butterworth
Kate Culshaw
Christopher Probert
机构：
[1] University of Liverpool,Henry Wellcome Laboratory, Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, Royal Liverpool University Hospital
[2] Wirral University Teaching Hospital,undefined
[3] Biomathematics and Statistics Scotland,undefined
[4] Newcastle upon Tyne Hospitals,undefined
[5] Cambridge University Hospitals,undefined
[6] St Mark’s Hospital,undefined
[7] James Cook University Hospital,undefined
[8] Queen Elizabeth Hospital Birmingham,undefined
[9] Shrewsbury and Telford Hospital,undefined
[10] Liverpool Cancer Trials Unit,undefined
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Crohn’s disease; Antibiotics; Ciprofloxacin; Doxycycline; Hydroxychloroquine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2700 / 2711
页数：11
相关论文
共 50 条
  • [21] Oral budesonide is as effective as oral prednisolone in active Crohn's disease
    Campieri, M
    Ferguson, A
    Doe, W
    Persson, T
    Nilsson, LG
    Malchow, H
    Prantera, C
    Mani, V
    OMorain, C
    Selby, W
    Pallone, F
    diPietralata, MM
    Sjodahl, R
    Florin, T
    Smith, P
    Bianchi, P
    Lofberg, R
    Rutgeerts, P
    Smallwood, R
    Lamers, HW
    TasmanJones, C
    Hunter, JO
    Hodgson, H
    Danielsson, A
    Lee, FI
    Piacitelli, G
    Giovanni, S
    Ellis, A
    Weir, DG
    GUT, 1997, 41 (02) : 209 - 214
  • [22] Effects of budesonide therapy on quality of life in active Crohn's disease
    Irvine, EJ
    CROHN'S DISEASE - PATHOGENESIS AND MEDICAL THERAPY, 1996, 18 (01): : 81 - 89
  • [23] Polymeric versus elemental diet as primary treatment in active Crohn's disease:: A randomized, double-blind trial
    Verma, S
    Brown, S
    Kirkwood, B
    Giaffer, MH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (03): : 735 - 739
  • [24] Oral budesonide for Crohn's disease
    Lofberg, R
    TRENDS IN INFLAMMATORY BOWEL DISEASE THERAPY 1996, 1997, : 99 - 110
  • [25] Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease
    Gross, V
    Andus, T
    Caesar, I
    Bischoff, SC
    Lochs, H
    Tromm, A
    Schulz, HJ
    Bar, U
    Weber, A
    Gierend, M
    Ewe, K
    Scholmerich, J
    Adam, B
    Bauerle, H
    Goebell, H
    Hoffmann, R
    Jakob, G
    Junge, U
    LorenzMeyer, H
    Manns, MP
    May, B
    Malchow, H
    Riemann, JF
    Schmidt, C
    Seifert, E
    Tillinger, W
    Vogelsang, H
    Wordehoff, D
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (09) : 905 - 909
  • [26] Certolizumab Pegol for Active Crohn's Disease: A Placebo-Controlled, Randomized Trial
    Sandborn, William J.
    Schreiber, Stefan
    Feagan, Brian G.
    Rutgeerts, Paul
    Younes, Ziad H.
    Bloomfield, Ralph
    Coteur, Geoffroy
    Guzman, Juan Pablo
    D'Haens, Geert R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (08) : 670 - U84
  • [27] Comparison of Two Dosing Methods for Induction of Response and Remission with Oral Budesonide in Active Pediatric Crohn's Disease: A Randomized Placebo-Controlled Trial
    Levine, Arie
    Kori, Michal
    Dinari, Gabriel
    Broide, Efrat
    Shaoul, Ron
    Yerushalmi, Baruch
    On, Avi
    Bujanover, Yoram
    Proels, Markus
    Greinwald, Roland
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (07) : 1055 - 1061
  • [28] Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease
    Maeda, Y.
    Ng, S. C.
    Durdey, P.
    Burt, C.
    Torkington, J.
    Rao, P. Kumar Dhruva
    Mayberry, J.
    Moshkovska, T.
    Stone, C. D.
    Carapeti, E.
    Vaizey, C. J.
    BRITISH JOURNAL OF SURGERY, 2010, 97 (09) : 1340 - 1347
  • [29] Quality of life rapidly improves with budesonide therapy for active Crohn's disease
    Irvine, EJ
    Greenberg, GR
    Feagan, BG
    Martin, F
    Sutherland, LR
    Thomson, ABR
    Nilsson, LG
    Persson, T
    INFLAMMATORY BOWEL DISEASES, 2000, 6 (03) : 181 - 187
  • [30] Budesonide and Mesalazine in active Crohn's disease: A comparison of the effects on quality of life
    Thomsen, OO
    Cortot, A
    Jewell, D
    Wright, JP
    Winter, T
    Veloso, FT
    Vatn, M
    Persson, T
    Pettersson, E
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (03): : 649 - 653
12345